C-Path and Vivpro join forces to advance drug development

FHS
July 14, 2023
2:57 am

Critical Path Institute, a leading global nonprofit committed to expediting drug development through the acceleration of regulatory-endorsed solutions, today announced a newly formalized Memorandum of Understanding with Vivpro, an industry-leading provider of a revolutionary biointelligence software platform and innovative services.

From Chaos to Calm: How ER Scheduling Could Help Fix Emergency Care Challenges

Sridhar Yerramreddy, CEO & Founder of Steer Health Staffing shortages and rising costs leave ERs in chaos and even force some hospitals to shut down

January 11, 2024

AbbVie gets first taste of Elahere potential with new mid-stage win

AbbVie’s $10.1 billion purchase of ImmunoGen and accompanying antibody-drug conjugate Elahere is already paying off, with the drug scoring a new mid-stage victory. The Chicago

June 7, 2024

How UnitedHealth’s acquisition of a popular Medicare Advantage algorithm sparked internal dissent over denied care

Frustration was boiling into open conflict within NaviHealth, a company that uses computer predictions to help control the cost of caring for millions of older

July 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.